It’s time to move omnichannel from discussion to reality using the steps: Observe, Plan, Engage and Nurture.
This article discusses how to foster innovation within and across the Medical Affairs landscape, empower teams to deliver the best outcomes for patients and revolutionize healthcare delivery.
In this podcast, MAPS speaks with experts from Pfizer and Putnam Associates about the most exciting current uses of AI and also where we may be headed in the future.
The MAPS Executive Consortium details how Medical Affairs will drive the evolution of industry to match the needs of a changing society.
MAPS speaks with Liz de Somer, CEO of Medicines Australia and Sharon Winton, CEO of Lymphoma Australia to explore patient engagement from the perspectives of industry and patient associations.
This podcast reviews new ways of identifying and quantifying opportunities for field medical impact with disease-state analytics.
MAPS speaks with Amit Lalwani, omnichannel lead and member of the Core Planning Team for the MAPA/MAPS Medical Affairs Summit, Nov 8-10, 2023 in Sydney, AU.
The combined impact of treatment complexity and data availability highlights the value of Medical Affairs departments that have the capability to make clinical sense of new disruptive drugs, devices, real-time monitoring and diagnostics. Here, the MAPS Executive Consortium describes how.
This paper provides a vision describing how Gen AI technologies will reshape the possibilities and practice of Medical Affairs related to the four functional pillars of Strategy & Leadership, Evidence & Insights Generation, Evidence & Insights Communication, and Engagement & Partnerships.
Thank you MAPS Partner Circle members for sharing use cases that bring to life MAPS’ Vision for Generative Artificial Intelligence in Medical Affairs.